Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced asymmetric total-synthesis method for chiral Huperzine A using Cinchona alkaloids. Delivers high optical purity and scalable manufacturing for Alzheimer's therapeutics.
Patent CN102464672A discloses a novel mannitol-based ligand for asymmetric catalysis, offering high enantioselectivity and simplified synthesis for cost-effective pharmaceutical manufacturing.
Patent CN110194735B details a visible light catalytic method for chiral amines. Offers high ee values and metal-free conditions for efficient API intermediate manufacturing.
Novel ester-based route for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-benzyl carbamate eliminates Pd/C, reducing costs and improving scalability for chiral catalyst manufacturing.
Patent CN114105972B reveals a novel cinchonine derivative boosting enantioselectivity to over 90 percent for indoxacarb synthesis, offering significant cost and supply chain advantages.
Patent CN119431279B reveals a novel Ir-catalyzed asymmetric hydrogenation route for chiral cyclic ethers, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN108912055B details a catalytic asymmetric dihydroxylation route for antiviral intermediates, offering cost-effective and scalable manufacturing solutions for global supply chains.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.
Novel axial and central chirality catalyst enables high enantioselectivity. Reduces costs in pharmaceutical intermediates manufacturing with scalable synthesis.
Patent CN100478333C reveals a novel route for chiral bis-imidazolinylbenzene compounds using amino alcohols, offering cost-effective solutions for asymmetric catalysis ligands.
Patent CN113501766B details a novel asymmetric synthesis route for difluoroalkyl cyclopentenones using visible light catalysis, offering high purity and cost reduction in pharmaceutical manufacturing.
Patent CN115850336B reveals metal-free synthesis for high-purity axial chiral compounds. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel one-pot two-step method using Iron(II) phthalocyanine for high-purity pharmaceutical intermediates with reduced costs and enhanced supply chain reliability.
Novel asymmetric synthesis of Beclabuvir intermediate via chiral copper catalysis. High yield, >99% ee, scalable process for API manufacturing.
Patent CN103044402B details a low-cost chiral oxidation route for Esomeprazole Sodium, offering high purity and supply chain stability for API manufacturing.
Novel asymmetric catalytic synthesis of chiral nitrogen-bridged rings. High stereoselectivity, scalable process for pharmaceutical intermediates and supply chain reliability.
Novel copper-catalyzed asymmetric propargyl substitution method ensures high ee and scalable production for pharmaceutical intermediates.
Patent CN109810125A reveals aqueous Henry reaction breakthrough enabling cost reduction in pharmaceutical intermediates manufacturing with high-purity pharmaceutical intermediates.
Patent CN105017150A details a palladium-catalyzed asymmetric hydrogenation method for high-purity chiral exocyclic amines, offering significant supply chain and cost advantages.
Patent CN112824422B discloses a novel chiral ligand enabling high TON asymmetric hydrogenation for pharma intermediates with simplified synthesis.